Veronis Suhler Stevenson (VSS), a private investment firm investing in the healthcare, information, business services and education industries, has made a significant growth investment to recapitalise Endo1 Partners (Endo1), a fast-growing specialty dental services organisation headquartered in Houston.
VSS has partnered with co-founders Dr Matthew Haddad, Dr Daryl Dudum, Dr Mark Haddad, and Dr Darron Rishwain. Terms of the private transaction have not been disclosed.
Formed in 2019 with operations in Texas and California, Endo1 provides comprehensive knowledge, resources and shared back-office support to endodontists across the country through an Endodontic Partnership Organization (“EPO”). Endo1’s offering empowers endodontists’ ability to provide best in class patient care and experience in their core specialty – the diagnosis, prevention and treatment of injuries to the pulp, including root canals treatment and other procedures related to the interior of the tooth. With VSS’ investment, Endo1 will accelerate its expansion through strategic acquisitions of complementary endodontic practices benefiting from a large and highly fragmented market totalling USD1.3 billion currently and expected to grow at 5.5 per cent annually to reach USD1.6 billion by 2022, according to industry data.
“We are thrilled to partner with Matthew, Daryl, Mark and Darron, as they continue to build a nationwide EPO platform providing like-minded endodontists with the opportunity to grow their practices, greatly reduce administrative and business burdens, and spend more time caring for their patients,” says Jeffrey Stevenson, Managing Partner of VSS. “Our investment in Endo1 is well aligned with VSS’ strategy of supporting experienced healthcare executives with flexible capital solutions to take their businesses to the next level.”
“We are excited to partner with VSS, whose extensive experience in the healthcare sector and strong network of relationships will help Endo1 reach its ambitious goals,” says Dr Matthew Haddad.
Dr Daryl Dudum adds: “VSS shares our vision for growing nationally and allowing our endodontist members to do what they do best: focus on providing high quality compassionate care to patients.”
“We are pleased to support the Endo1 team with VSS’s financial and operational resources as they continue to build relationships with endodontists across the country. VSS’ investment in Endo1 is reflective of the firm’s proven ability to partner with entrepreneurs of highly scalable businesses and identify acquisitions that generate growth and position them for long term success,” says Yash Kandoi, Director at VSS.
